EMETOSTOP 30mg tablets medication leaflet

R06AE05 meclozine • Respiratory system | Antihistamines for systemic use | Piperazine derivatives

Meclozine is a medication used to prevent and treat nausea, vomiting, and dizziness associated with motion sickness, vertigo, or other inner ear disorders such as Ménière's disease. It belongs to the class of H1 antihistamines and works by blocking histamine receptors in the brain, thereby reducing the sensation of nausea and dizziness.

Meclozine is available in tablet form and can be taken 1-2 hours before travel to prevent motion sickness. It is also sometimes used to treat nausea during pregnancy, but only under medical supervision.

Side effects may include drowsiness, dry mouth, fatigue, blurred vision, or, in rare cases, allergic reactions. Patients should avoid alcohol consumption or operating vehicles during treatment, as meclizine may impair alertness.

EMETOSTOP 30mg tablets SPECIFAR, meclozine

General data about EMETOSTOP 30mg

Substance: meclozine

Date of last drug list: 01-05-2024

Commercial code: W13788001

Concentration: 30mg

Pharmaceutical form: tablets

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: SPECIFAR S.A. - GRECIA

Holder: SPECIFAR S.A. - GRECIA

Number: 7611/2015/01

Shelf life: 3 years

Other substances similar to meclozine